• About
  • Products
  • News
  • Corporate
  • Investor
    • Financial
    • Stock
  • Contact
PanGenomic Health Subsidiary, MUJN Diagnostics, Announces the Engagement of Hemex Health to Assist in the Development of Brain Health Diagnostics System

PanGenomic Health Subsidiary, MUJN Diagnostics, Announces the Engagement of Hemex Health to Assist in the Development of Brain Health Diagnostics System

by PanGenomic | Mar 30, 2023 | Business Update

Vancouver, British Columbia, Canada, March 30, 2023 – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. (“MUJN Diagnostics”), has signed a master services agreement with Hemex Health...
PanGenomic Health Announces the Filing of a Business Acquisition Report for Mindleap Health and Provides Update on UK Listing

PanGenomic Health Announces the Filing of a Business Acquisition Report for Mindleap Health and Provides Update on UK Listing

by PanGenomic | Mar 28, 2023 | Business Update

VANCOUVER, BC, March 28, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce the filing of its business acquisition report (the “BAR”) relating to its acquisition of...
Circle Innovation to Support PanGenomic Health Subsidiary, MUJN Diagnostics, with the Development of its Decision Support System

Circle Innovation to Support PanGenomic Health Subsidiary, MUJN Diagnostics, with the Development of its Decision Support System

by PanGenomic | Mar 22, 2023 | Business Update

VANCOUVER, BC, March 8, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce that its new Women’s DNA Report is now available and that it has expanded into new...
PanGenomic Health Announces Availability of Women’s Hormonal Health DNA Report

PanGenomic Health Announces Availability of Women’s Hormonal Health DNA Report

by PanGenomic | Mar 9, 2023 | Business Update

VANCOUVER, BC, March 8, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce that its new Women’s DNA Report is now available and that it has expanded into new...
PanGenomic Health Provides Corporate Update

PanGenomic Health Provides Corporate Update

by PanGenomic | Mar 2, 2023 | Business Update

VANCOUVER, BC, March 2, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to provide a corporate update on its strategic initiatives. Acquisition of Mindleap Health Inc....
« Older Entries

Recent Posts

  • PanGenomic Health Subsidiary, MUJN Diagnostics, Announces the Engagement of Hemex Health to Assist in the Development of Brain Health Diagnostics System
  • PanGenomic Health Announces the Filing of a Business Acquisition Report for Mindleap Health and Provides Update on UK Listing
  • Circle Innovation to Support PanGenomic Health Subsidiary, MUJN Diagnostics, with the Development of its Decision Support System
  • PanGenomic Health Announces Availability of Women’s Hormonal Health DNA Report
  • PanGenomic Health Provides Corporate Update

Recent Comments

No comments to show.
  • Follow
  • Follow
  • Follow
  • Follow

GET IN TOUCH

info@pangenomic.com

ABOUT US

Privacy Policy

Our Story

NEWSLETTER

Contact Us

© 2023 PanGenomic Health Inc.
A public benefit company.